Results 21 to 30 of about 2,019 (146)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA

Emerging Infectious Diseases, 2023
We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat.
Maura K. Lash, Ned H. Latham, Pui Ying Chan, Mary M.K. Foote, Elizabeth A. Garcia, Matthew F. Silverstein, Marcia Wong, Mark Alexander, Karen A. Alroy, Lovedeep Bajaj, Kuan Chen, James Steele Howard, Lucretia E. Jones, Ellen H. Lee, Julian L. Watkins, Tristan D. McPherson   +15 more
doaj   +1 more source

Oral Tecovirimat for the Treatment of Smallpox [PDF]

New England Journal of Medicine, 2018
Smallpox was declared eradicated in 1980, but variola virus (VARV), which causes smallpox, still exists. There is no known effective treatment for smallpox; therefore, tecovirimat is being developed as an oral smallpox therapy. Because clinical trials in a context of natural disease are not possible, an alternative developmental path to evaluate ...
Laudisoit, Anne, Tepage, Floribert, Colebunders, Robert   +2 more
openaire   +5 more sources

Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review

Global Biosecurity, 2019
Background: In a global political climate increasingly concerned about terrorism, bioterrorism agents such as smallpox would undoubtedly be catastrophic.
Joyce Yu, Suresh Mahendra Raj
doaj   +1 more source

Monkeypox - new epidemiological threat? Review of the current literature

Journal of Education, Health and Sport, 2023
The mokeypox is zoonotic disease caused by an orthopoxvirus, which was first isolated and identified in 1959 among captive monkeys transported to Copenhagen, Denmark from Africa for research purposes.
Dominika Jarosz, Aleksandra Grudzińska, Paulina Dudzińska, Małgorzata Milanowska, Hanna Tsitko   +4 more
doaj   +1 more source

Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks

Health Science Reports, 2022
Background and aims There is a sought for vaccines and antiviral agents as countermeasures for the recent monkeypox outbreak. Here, we aimed to review and discuss the repurposing potentials of smallpox vaccines and drugs in monkeypox outbreaks based on ...
Md. Rabiul Islam, Md. Jamal Hossain, Arpita Roy, A. H. M. Nazmul Hasan, Md. Ashrafur Rahman, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan   +6 more
doaj   +1 more source

Monkeypox - review

Journal of Education, Health and Sport, 2022
Introduction and purpose:  This review aims to analyze the current information about monkeypox and the virus which causes the disease.  Material and method: This review was based on articles collected in PubMed and published in the years 2012-2022
Aleksandra Amalia Kuchnicka, Katarzyna Kosz, Julia Kuchnicka, Klaudia Remjasz, Natalia Zarankiewicz, Martyna Zielińska, Klaudia Sapuła, Jakub Aleksandrowicz, Wojciech Siedlecki   +8 more
doaj   +1 more source

Toxicological Potential of the FDA-Approved Treatment against Monkeypox. Comment on Zovi et al. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. Int. J. Mol. Sci. 2022, 23, 15941

International Journal of Translational Medicine, 2023
Recently, some drugs were approved to control Monkeypox (MPX), among them tecovirimat. This was recently approved by regulatory agencies around the world, the paper of Zovi et al entitled Pharmacological Agents with Antiviral Activity against Monkeypox ...
Gabriel Christian de Farias Morais, Umberto Laino Fulco, Edilson Dantas da Silva, Claudio Bruno Silva de Oliveira, Jonas Ivan Nobre Oliveira   +4 more
doaj   +1 more source

Mpox in South Asia: A Narrative Review on Epidemiology, Preparedness, and Preventive Strategies. [PDF]

Health Sci Rep
ABSTRACT Background and Aims Monkeypox (Mpox), due to its growing global concern, was declared a public health emergency of worldwide concern by the World Health Organization in August 2024. The monkeypox virus (MPXV), once limited to African regions, has now spread to South Asia, including Pakistan, India, Nepal, and Sri Lanka, and there have been ...
Mawa J, Rimun SN, Rahman NZ, Bhuiyan MA, Shahriar M, Anjum R.   +5 more
europepmc   +2 more sources

Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis

Frontiers in Pharmacology, 2023
Mpox (earlier known as monkeypox) virus infection is a recognized public health emergency. There has been little research on the treatment options. This article reviews the specific drugs used to treat mpox virus infection and the vaccines used here ...
Muhammad Aaqib Shamim, Prakisini Satapathy, Bijaya Kumar Padhi, Sai Dutt Veeramachaneni, Naushaba Akhtar, Anindita Pradhan, Abhimanyu Agrawal, Pradeep Dwivedi, Pradeep Dwivedi, Aroop Mohanty, Keerti Bhusan Pradhan, Russell Kabir, Ali A. Rabaan, Jawaher Alotaibi, Zainab A. Al Ismail, Zainab Ahmed Alsoliabi, Ali Al Fraij, Ranjit Sah, Ranjit Sah, Ranjit Sah, Alfonso J. Rodriguez-Morales, Alfonso J. Rodriguez-Morales   +21 more
doaj   +1 more source

Computational Purposing Phytochemicals against Cysteine Protease of Monkeypox Virus: An In-silico Approach

Journal of Pure and Applied Microbiology, 2022
The development and evolution of viruses that cause disease have presented a formidable challenge to contemporary medicine and the global economy, not to mention a catastrophic risk to human health.
Poonam Bansal, Mahiti Gupta, Sonali Sangwan, Gurpreet Kaur Bhatia, Seema Ramniwas, Deepak Chandran, Abhijit Dey, Kuldeep Dhama, Hardeep Singh Tuli   +8 more
doaj   +1 more source